Celldex Therapeutics
CLDX
CLDX
130 hedge funds and large institutions have $645M invested in Celldex Therapeutics in 2020 Q4 according to their latest regulatory filings, with 53 funds opening new positions, 33 increasing their positions, 24 reducing their positions, and 13 closing their positions.
Holders
130
Holders Change
+39
Holders Change %
+42.86%
% of All Funds
2.31%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
53
Increased
33
Reduced
24
Closed
13
Calls
$11.8M
Puts
$8.52M
Net Calls
+$3.25M
Net Calls Change
-$3.81M
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
LGM
126
Logos Global Management
San Francisco,
California
| – | -$17.8M | -1,200,000 | Closed |
|
|
O
127
OrbiMed
New York
| – | -$9.27M | -625,000 | Closed |
|
128
Invesco
Atlanta,
Georgia
| – | -$7.93M | -534,584 | Closed |
|
|
RCM
129
RA Capital Management
Boston,
Massachusetts
| – | -$5.24M | -353,072 | Closed |
|
|
EP
130
Eversept Partners
New York
| – | -$2.23M | -150,494 | Closed |
|
|
PVI
131
Pura Vida Investments
New York
| – | -$2.14M | -144,200 | Closed |
|
|
JGC
132
J. Goldman & Co
New York
| – | -$1.13M | -76,055 | Closed |
|
|
PA
133
Perceptive Advisors
New York
| – | -$738K | -49,751 | Closed |
|
|
WG
134
Winton Group
London,
United Kingdom
| – | -$359K | -24,180 | Closed |
|
|
PFS
135
Prospera Financial Services
Dallas,
Texas
| – | -$55K | -3,738 | Closed |
|
|
FIA
136
FNY Investment Advisers
New York
| – | -$29K | -2,000 | Closed |
|